Cite
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial.
MLA
Pittet, Laure F., et al. “Prevention of Infant Eczema by Neonatal Bacillus Calmette‐Guérin Vaccination: The MIS BAIR Randomized Controlled Trial.” Allergy, vol. 77, no. 3, Mar. 2022, pp. 956–65. EBSCOhost, https://doi.org/10.1111/all.15022.
APA
Pittet, L. F., Messina, N. L., Gardiner, K., Freyne, B., Abruzzo, V., Francis, K. L., Morrison, C., Zufferey, C., Vuillermin, P., Allen, K. J., Ponsonby, A., Robins, B. R., Shann, F., Flanagan, K. L., Phillips, R., Donath, S., Casalaz, D., & Curtis, N. (2022). Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial. Allergy, 77(3), 956–965. https://doi.org/10.1111/all.15022
Chicago
Pittet, Laure F., Nicole L. Messina, Kaya Gardiner, Bridget Freyne, Veronica Abruzzo, Kate L. Francis, Clare Morrison, et al. 2022. “Prevention of Infant Eczema by Neonatal Bacillus Calmette‐Guérin Vaccination: The MIS BAIR Randomized Controlled Trial.” Allergy 77 (3): 956–65. doi:10.1111/all.15022.